Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea

Documenti analoghi

• System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment
  di: B. Joy Snider, et al.
  Pubblicazione: (2025)
• Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
  di: Luke E. Stoeckel, et al.
  Pubblicazione: (2025)
• Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective
  di: Khushbu J. Patel, et al.
  Pubblicazione: (2024)
• Early Alzheimer's disease patient care pathway and health system readiness: A framework for integrated care
  di: Ilya M. Nasrallah, et al.
  Pubblicazione: (2025)
• AI approaches for phenotyping Alzheimer's disease and related dementias using electronic health records
  di: Sara Knox, et al.
  Pubblicazione: (2025)